https://www.sciencedaily.com/news/health_medicine/leukemia/ Read the latest medical research and information on leukemia. Learn about the symptoms and diagnosis of chronic myeloid leukemia (CML) and other leukemia types. What new leukemia treatments are under development? en-us Wed, 22 Apr 2026 09:22:46 EDT Wed, 22 Apr 2026 09:22:46 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/leukemia/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/04/260407073850.htm Vitamin D levels in midlife may play a bigger role in long-term brain health than previously thought. In a study following nearly 800 people over 16 years, those with higher vitamin D levels in their 30s and 40s had lower levels of tau protein later on, a key marker linked to dementia. Tue, 07 Apr 2026 07:47:09 EDT https://www.sciencedaily.com/releases/2026/04/260407073850.htm https://www.sciencedaily.com/releases/2026/03/260317015933.htm mRNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA nanostructures to better control how the immune system responds. In early studies, it produced strong antibody and T cell responses in both mice and human models. Researchers say it could lead to more stable, easier-to-manufacture vaccines for diseases like COVID-19, HIV, and Ebola. Tue, 17 Mar 2026 01:59:33 EDT https://www.sciencedaily.com/releases/2026/03/260317015933.htm https://www.sciencedaily.com/releases/2026/03/260315001845.htm A major clinical trial has delivered an unexpected twist in the search for ways to fight COVID-19 and its lingering effects. Researchers at Mass General Brigham found that taking high doses of vitamin D3 did not make COVID-19 infections less severe or reduce hospital visits. However, the study uncovered a subtle but intriguing signal suggesting that people who consistently took vitamin D supplements might be slightly less likely to develop long COVID symptoms weeks after infection. Sun, 15 Mar 2026 05:54:54 EDT https://www.sciencedaily.com/releases/2026/03/260315001845.htm https://www.sciencedaily.com/releases/2026/03/260303050624.htm Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it. The key player, a gene called GATA6, keeps tumours in a more structured and treatable form—but it gets shut down by an overactive KRAS-driven pathway. When researchers blocked that pathway, GATA6 levels rebounded and cancer cells became more sensitive to chemo. The discovery could help turn some of the toughest pancreatic tumours into ones doctors can better control. Tue, 03 Mar 2026 11:33:04 EST https://www.sciencedaily.com/releases/2026/03/260303050624.htm https://www.sciencedaily.com/releases/2026/02/260204114343.htm As bird flu continues to circulate in animals and spill over into humans, researchers are racing to stop it before it adapts to spread widely between people. A new nasal spray vaccine showed strong protection against H5N1 in animal tests, outperforming traditional flu shots. Because it targets the nose and lungs, it may prevent infection at the earliest stage. Wed, 04 Feb 2026 11:43:43 EST https://www.sciencedaily.com/releases/2026/02/260204114343.htm https://www.sciencedaily.com/releases/2026/01/260115022808.htm A vitamin A byproduct has been found to quietly disarm the immune system, allowing tumors to evade attack and weakening cancer vaccines. Scientists have now developed a drug that shuts down this pathway, dramatically boosting immune responses and slowing cancer growth in preclinical studies. Fri, 16 Jan 2026 06:06:55 EST https://www.sciencedaily.com/releases/2026/01/260115022808.htm https://www.sciencedaily.com/releases/2025/12/251228020010.htm A randomized trial from Vanderbilt-Ingram Cancer Center reveals that magnesium may be the missing key to keeping vitamin D levels in balance. The study found that magnesium raised vitamin D in people who were deficient while dialing it down in those with overly high levels—suggesting a powerful regulating effect. This could help explain why vitamin D supplements don’t work the same way for everyone and why past studies linking vitamin D to cancer and heart disease have produced mixed results. Sun, 28 Dec 2025 02:00:10 EST https://www.sciencedaily.com/releases/2025/12/251228020010.htm https://www.sciencedaily.com/releases/2025/12/251226045343.htm Vitamin C doesn’t just belong in skincare products—it works even better when you eat it. Scientists discovered that vitamin C from food travels through the bloodstream into every layer of the skin, boosting collagen and skin renewal. People who ate two vitamin C–packed kiwifruit daily showed thicker, healthier skin. The findings suggest glowing skin really does start from within. Fri, 26 Dec 2025 11:18:28 EST https://www.sciencedaily.com/releases/2025/12/251226045343.htm https://www.sciencedaily.com/releases/2025/12/251219093309.htm In a rare and historic achievement, Children’s Hospital Colorado successfully completed its first dual heart and liver transplant in a pediatric patient. The life-saving surgery was performed on 11-year-old Gracie Greenlaw, whose congenital heart condition eventually led to liver failure. Dozens of specialists worked together for years to prepare for a moment like this, executing a complex, 16-hour operation. Now months later, Gracie is home, in school, and thriving. Fri, 19 Dec 2025 10:35:40 EST https://www.sciencedaily.com/releases/2025/12/251219093309.htm https://www.sciencedaily.com/releases/2025/12/251213032619.htm Forskolin, a plant-derived compound, shows surprising potential against one of the most aggressive forms of leukemia. Researchers discovered that it not only stops cancer cells from growing but also makes them far more vulnerable to chemotherapy by preventing them from pumping out the drugs meant to kill them. Experts say this dual action could help create safer, more powerful AML treatments with fewer harsh side effects. Sun, 14 Dec 2025 09:37:38 EST https://www.sciencedaily.com/releases/2025/12/251213032619.htm https://www.sciencedaily.com/releases/2025/12/251211040438.htm A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest forms of blood cancer, T-cell acute lymphoblastic leukaemia. By precisely rewriting tiny sections of DNA, scientists at UCL and Great Ormond Street Hospital created universal CAR T-cells capable of targeting the cancer without harming themselves—a long-standing challenge in T-cell–based therapies. Early trial results show deep, long-lasting remissions, including in patients who had exhausted standard treatment options. Thu, 11 Dec 2025 04:14:40 EST https://www.sciencedaily.com/releases/2025/12/251211040438.htm https://www.sciencedaily.com/releases/2025/12/251203004721.htm A unique vaccine rollout in Wales gave researchers an accidental natural experiment that revealed a striking reduction in dementia among seniors who received the shingles vaccine. The protective effect held steady across multiple analyses and was even stronger in women. Evidence also suggests benefits for people who already have dementia, hinting at a therapeutic effect. Wed, 03 Dec 2025 10:22:27 EST https://www.sciencedaily.com/releases/2025/12/251203004721.htm https://www.sciencedaily.com/releases/2025/11/251126095018.htm Researchers at Stanford found a way to cure or prevent Type 1 diabetes in mice using a combined blood stem cell and islet cell transplant. The procedure creates a hybrid immune system that stops autoimmune attacks and eliminates the need for immune-suppressing drugs. The method uses tools already common in clinical practice, putting human trials within reach. Scientists think the same strategy could transform treatments for autoimmune conditions and organ transplantation. Wed, 26 Nov 2025 12:05:21 EST https://www.sciencedaily.com/releases/2025/11/251126095018.htm https://www.sciencedaily.com/releases/2025/11/251118220049.htm Researchers discovered that chronic inflammation fundamentally remodels the bone marrow, allowing mutated stem cell clones to quietly gain dominance with age. Reprogrammed stromal cells and interferon-responsive T cells create a self-sustaining inflammatory loop that weakens blood production. Surprisingly, the mutant cells themselves may not be the main instigators. Tue, 18 Nov 2025 22:00:49 EST https://www.sciencedaily.com/releases/2025/11/251118220049.htm https://www.sciencedaily.com/releases/2025/11/251110021043.htm Intermountain Health researchers discovered that customizing vitamin D3 doses for heart attack survivors slashed their risk of another heart attack by 50%. The strategy involved frequent monitoring and dose adjustments to reach ideal vitamin D levels. Traditional studies didn’t track blood levels, missing this critical link. Mon, 10 Nov 2025 07:45:02 EST https://www.sciencedaily.com/releases/2025/11/251110021043.htm https://www.sciencedaily.com/releases/2025/11/251107010324.htm A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanconi anemia to receive stem cell transplants safely. The antibody, briquilimab, removes diseased stem cells without radiation, enabling nearly complete donor cell replacement. The approach also widens donor eligibility and could soon be applied to other bone marrow failure diseases. Fri, 07 Nov 2025 22:28:44 EST https://www.sciencedaily.com/releases/2025/11/251107010324.htm https://www.sciencedaily.com/releases/2025/11/251105050718.htm A Northwestern team transformed a common chemotherapy drug into a powerful, targeted cancer therapy using spherical nucleic acids. The redesign dramatically boosted drug absorption and cancer-killing power while avoiding side effects. This innovation may usher in a new era of precision nanomedicine for cancer and beyond. Wed, 05 Nov 2025 23:23:15 EST https://www.sciencedaily.com/releases/2025/11/251105050718.htm https://www.sciencedaily.com/releases/2025/10/251027224837.htm Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing immunotherapy. The vaccine appears to prime the immune system in a powerful, nonspecific way, enhancing cancer treatment outcomes. If confirmed, the discovery could lead to a universal cancer vaccine and transform oncology care. Tue, 28 Oct 2025 09:47:26 EDT https://www.sciencedaily.com/releases/2025/10/251027224837.htm https://www.sciencedaily.com/releases/2025/10/251019120503.htm A groundbreaking study reveals that cancer patients who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy lived dramatically longer than those who didn’t. Researchers from the University of Florida and MD Anderson Cancer Center discovered that the vaccine’s immune-activating properties may boost cancer-fighting responses, acting like a nonspecific “flare” that reawakens the immune system. Sun, 19 Oct 2025 12:43:31 EDT https://www.sciencedaily.com/releases/2025/10/251019120503.htm https://www.sciencedaily.com/releases/2025/10/251014014312.htm Researchers have synthesized enhanced vitamin K analogues that outperform natural vitamin K in promoting neuron growth. The new compounds, which combine vitamin K with retinoic acid, activate the mGluR1 receptor to drive neurogenesis. They also efficiently cross the blood-brain barrier and show stability in vivo. This discovery could pave the way for regenerative treatments for Alzheimer’s and related diseases. Tue, 14 Oct 2025 11:08:36 EDT https://www.sciencedaily.com/releases/2025/10/251014014312.htm https://www.sciencedaily.com/releases/2025/10/251004092911.htm Scientists discovered that vitamin D2 supplements can lower levels of vitamin D3, the form the body uses most effectively. Unlike D2, vitamin D3 enhances the immune system’s first line of defense against infections. This raises questions about which type of supplement should be prioritized. Sat, 04 Oct 2025 11:34:43 EDT https://www.sciencedaily.com/releases/2025/10/251004092911.htm https://www.sciencedaily.com/releases/2025/09/250929054920.htm Scientists discovered that inhibiting the enzyme STK17B forces multiple myeloma cells into iron-driven death and makes therapies more effective. Early mouse studies show strong potential for a new treatment approach. Mon, 29 Sep 2025 22:12:19 EDT https://www.sciencedaily.com/releases/2025/09/250929054920.htm https://www.sciencedaily.com/releases/2025/09/250921091002.htm Scientists have discovered that cancer uses a hidden hormone to switch off the body’s natural defenses, allowing tumors to grow unchecked. By uncovering this secret signal, they found a way to block it and restore the immune system’s ability to fight back. The breakthrough not only hints at powerful new cancer treatments but also suggests the same pathway could someday be used to calm autoimmune diseases. Mon, 22 Sep 2025 07:46:47 EDT https://www.sciencedaily.com/releases/2025/09/250921091002.htm https://www.sciencedaily.com/releases/2025/09/250916221917.htm Rogue DNA rings known as ecDNA may hold the key to cracking glioblastoma’s deadly resilience. Emerging before tumors even form, they could offer scientists a crucial early-warning system and a chance to intervene before the disease becomes untreatable. Wed, 17 Sep 2025 21:33:46 EDT https://www.sciencedaily.com/releases/2025/09/250916221917.htm https://www.sciencedaily.com/releases/2025/08/250818102951.htm A breakthrough mRNA cancer vaccine has shown the ability to supercharge the effects of immunotherapy in mice, sparking hope for a universal “off-the-shelf” treatment that could fight multiple cancers. Unlike traditional vaccines designed to target specific tumor proteins, this approach simply revs up the immune system as if it were fighting a virus. The results were dramatic—when paired with checkpoint inhibitors, tumors shrank, and in some cases, the vaccine alone wiped them out. Tue, 19 Aug 2025 02:22:25 EDT https://www.sciencedaily.com/releases/2025/08/250818102951.htm https://www.sciencedaily.com/releases/2025/06/250609060137.htm A breakthrough study from Keck Medicine of USC may have found a powerful new triple therapy for glioblastoma, one of the deadliest brain cancers. By combining Tumor Treating Fields (TTFields), which deliver electric waves into tumors, with immunotherapy and chemotherapy, researchers saw a major boost in survival. Mon, 09 Jun 2025 06:01:37 EDT https://www.sciencedaily.com/releases/2025/06/250609060137.htm https://www.sciencedaily.com/releases/2025/05/250521124803.htm Researchers have shown that gonadotrophs, cells in the pituitary gland with a key role in puberty and reproduction, come from two different populations, with the majority produced after birth rather than in the embryo, as previously thought. Wed, 21 May 2025 12:48:03 EDT https://www.sciencedaily.com/releases/2025/05/250521124803.htm https://www.sciencedaily.com/releases/2025/05/250521124450.htm An international study has uncovered why a widely used treatment for acute myeloid leukemia (AML) doesn't work for everyone. The findings could help doctors better match patients with the therapies most likely to work for them. Wed, 21 May 2025 12:44:50 EDT https://www.sciencedaily.com/releases/2025/05/250521124450.htm https://www.sciencedaily.com/releases/2025/05/250520224245.htm Scientists and medics have developed an ultra-rapid method of genetically diagnosing brain tumors that will cut the time it takes to classify them from 6-8 weeks, to as little as two hours.The team utilized the new approach during 50 brain tumor surgeries to deliver rapid, intraoperative diagnoses. This approach has achieved a 100% success rate, providing diagnostic results in under two hours from surgery and detailed tumor classifications within minutes of sequencing. Tue, 20 May 2025 22:42:45 EDT https://www.sciencedaily.com/releases/2025/05/250520224245.htm https://www.sciencedaily.com/releases/2025/05/250515145628.htm A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of the virus. Traditional approaches haven't worked -- largely because HIV mutates rapidly and hides key parts of itself from the immune system. Now, a new study combining data from two separate phase 1 clinical trials shows that a targeted vaccine strategy can successfully activate early immune responses relevant to HIV, and, in one trial, further advance them -- a key step toward a long-sought goal in vaccine development. Thu, 15 May 2025 14:56:28 EDT https://www.sciencedaily.com/releases/2025/05/250515145628.htm https://www.sciencedaily.com/releases/2025/05/250514111056.htm A study shows that leukemia cells drink up taurine, which is produced in the body and also consumed through foods and in energy drinks, and use it as fuel for growth. This highlights a potential to block taurine uptake as a possible treatment. Wed, 14 May 2025 11:10:56 EDT https://www.sciencedaily.com/releases/2025/05/250514111056.htm https://www.sciencedaily.com/releases/2025/04/250428220307.htm A highly sensitive bone marrow test could double survival rates for some groups of younger adults with Acute Myeloid Leukemia (AML) by helping doctors identify if they might relapse up to three months earlier. Mon, 28 Apr 2025 22:03:07 EDT https://www.sciencedaily.com/releases/2025/04/250428220307.htm https://www.sciencedaily.com/releases/2025/04/250423185925.htm Researchers have discovered that expansion of mutant blood cells, a phenomenon linked to aging, can be found in cancerous tumors, and this is associated with worse outcomes for patients. Wed, 23 Apr 2025 18:59:25 EDT https://www.sciencedaily.com/releases/2025/04/250423185925.htm https://www.sciencedaily.com/releases/2025/04/250416135226.htm A new study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months. Wed, 16 Apr 2025 13:52:26 EDT https://www.sciencedaily.com/releases/2025/04/250416135226.htm https://www.sciencedaily.com/releases/2025/04/250411112928.htm A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team identified a monoclonal antibody called KG2032 that reacts with a certain variant of the HLA-DRB1 molecule. KG2032 CAR T cells displayed strong anti-AML effects in a mouse model, and CAR natural killer cells showed similar results. Clinical trials are currently being planned. Fri, 11 Apr 2025 11:29:28 EDT https://www.sciencedaily.com/releases/2025/04/250411112928.htm https://www.sciencedaily.com/releases/2025/04/250410130742.htm Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer. Thu, 10 Apr 2025 13:07:42 EDT https://www.sciencedaily.com/releases/2025/04/250410130742.htm https://www.sciencedaily.com/releases/2025/04/250409155033.htm Chronic myeloid leukemia may seem to appear suddenly, but new research shows it begins years before diagnosis with an explosive surge of growth. Scientists tracked how a single genetic accident—the fusion of two genes into the notorious BCR::ABL1 "Philadelphia chromosome"—can spark runaway cell multiplication at rates up to 100,000% per year. This growth is so aggressive that it outpaces most other cancers, powered by just one mutation rather than the slow accumulation of many. Wed, 09 Apr 2025 15:50:33 EDT https://www.sciencedaily.com/releases/2025/04/250409155033.htm https://www.sciencedaily.com/releases/2025/04/250402122149.htm A unique vaccination rollout in Wales offered researchers a natural experiment: some older adults qualified for the shingles vaccine, while others just missed the cutoff. The results were striking — those who got the shot had a 20% lower risk of developing dementia within seven years. This breakthrough hints that viruses lurking in the nervous system may contribute to dementia and that prevention could be simpler than anyone imagined. Wed, 02 Apr 2025 12:21:49 EDT https://www.sciencedaily.com/releases/2025/04/250402122149.htm https://www.sciencedaily.com/releases/2025/04/250401131309.htm A team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumors in chicken eggs and analyzing their proteins. The team has combined these two techniques to identify and test a drug for a young patient's tumor in time to be used for their treatment. Their success in finding a new drug for the patient shows how the study of proteins, known as proteomics, can be a valuable complement to the established study of genes (genomics) in real-time cancer therapies. Tue, 01 Apr 2025 13:13:09 EDT https://www.sciencedaily.com/releases/2025/04/250401131309.htm https://www.sciencedaily.com/releases/2025/03/250327141419.htm Researchers have found that the clinical application of BCR::ABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to determine for which patients chronic drug treatment could potentially be discontinued. This transcript that is unique for CML is more sensitive and accurate than the current standard, real-time quantitative PCR (RT-qPCR), for detecting ultralow levels of residual leukemic disease. Thu, 27 Mar 2025 14:14:19 EDT https://www.sciencedaily.com/releases/2025/03/250327141419.htm https://www.sciencedaily.com/releases/2025/03/250319143643.htm A study has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine fails to offer sufficient protection. All at-risk groups, and people with HIV in particular, should therefore receive the second dose of the vaccine as recommended. Wed, 19 Mar 2025 14:36:43 EDT https://www.sciencedaily.com/releases/2025/03/250319143643.htm https://www.sciencedaily.com/releases/2025/03/250318141818.htm Small amounts of a common antibiotic and anti-inflammatory drug can curb symptoms where a misplaced immune reaction (e.g., autoimmunity) can cause permanent hair loss, a new study shows. This regimen may also come with fewer side effects than higher doses of the medication. Tue, 18 Mar 2025 14:18:18 EDT https://www.sciencedaily.com/releases/2025/03/250318141818.htm https://www.sciencedaily.com/releases/2025/03/250311121703.htm Researchers have identified genetic changes in blood stem cells from frequent blood donors that support the production of new, non-cancerous cells. Understanding the differences in the mutations that accumulate in our blood stem cells as we age is important to understand how and why blood cancers develop and hopefully how to intervene before the onset of clinical symptoms. Tue, 11 Mar 2025 12:17:03 EDT https://www.sciencedaily.com/releases/2025/03/250311121703.htm https://www.sciencedaily.com/releases/2025/02/250227212911.htm Red blood cells carry oxygen from the lungs to every other organ, and blood-forming stem cells must make about 200 billion new red blood cells each day to keep the oxygen flowing. For many years, scientists assumed that blood production took place in the bone marrow. But now, researchers are showing it's also happening in the lungs. Thu, 27 Feb 2025 21:29:11 EST https://www.sciencedaily.com/releases/2025/02/250227212911.htm https://www.sciencedaily.com/releases/2025/02/250227125112.htm Scientists have identified an innovative combination of treatment strategies that work collaboratively to effectively kill acute myeloid leukemia (AML) cells, a frequently incurable form of cancer. New research findings suggest that a class of drugs known as MCL-1 (myeloid leukemia cell-1) inhibitors interact with a type of kinase inhibitor that targets the SRC gene to efficiently trigger cell death in AML cells. Thu, 27 Feb 2025 12:51:12 EST https://www.sciencedaily.com/releases/2025/02/250227125112.htm https://www.sciencedaily.com/releases/2025/02/250226163234.htm New findings could help make immunotherapies for brain cancer more effective. The team analyzed almost 200,000 individual immune cells in tumor samples taken from patients with glioma, the most common and aggressive type of primary brain cancer. The researchers describe four gene expression 'programs' -- sets of genes with coordinated activity -- that either suppress the immune system or make it more active. Defining and understanding what drives these programs could one day help researchers target them with new drugs to dial up or down specific parts of the immune system to improve patient response to immunotherapy. Wed, 26 Feb 2025 16:32:34 EST https://www.sciencedaily.com/releases/2025/02/250226163234.htm https://www.sciencedaily.com/releases/2025/02/250225121634.htm A bone marrow transplant process is safe and curative for adults with sickle cell disease, according to results of a trial completed at about 20 cancer centers. Tue, 25 Feb 2025 12:16:34 EST https://www.sciencedaily.com/releases/2025/02/250225121634.htm https://www.sciencedaily.com/releases/2025/02/250213144435.htm When a tumour develops, it creates a structure around itself called the tumour stroma, within which blood and lymphatic vessels ensure nutritional and respiratory biological exchanges. Lymphangiogenesis, i.e. the development of lymphatic vessels, is generally associated with a poor prognosis, as it favours the spread of metastases to other organs. By studying the cells that make up the wall of lymphatic vessels, a team has made an unexpected discovery: an enzyme they express appears to play a key role in supporting immune cells, particularly when they are activated by anti-tumor treatments. These results could pave the way for improving the effectiveness of immunotherapies. Thu, 13 Feb 2025 14:44:35 EST https://www.sciencedaily.com/releases/2025/02/250213144435.htm https://www.sciencedaily.com/releases/2025/02/250210133016.htm Breast cancers at all stages are defined by the structure of their genomes, researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues. Mon, 10 Feb 2025 13:30:16 EST https://www.sciencedaily.com/releases/2025/02/250210133016.htm https://www.sciencedaily.com/releases/2025/02/250210132403.htm When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers report. The detailed insights into cancer progression could advance diagnostics and treatment. Mon, 10 Feb 2025 13:24:03 EST https://www.sciencedaily.com/releases/2025/02/250210132403.htm https://www.sciencedaily.com/releases/2025/02/250207133429.htm A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research. Fri, 07 Feb 2025 13:34:29 EST https://www.sciencedaily.com/releases/2025/02/250207133429.htm https://www.sciencedaily.com/releases/2025/02/250207122748.htm Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to macrophage-based therapies, and clues behind why these tumors don't respond to existing immunotherapies. Fri, 07 Feb 2025 12:27:48 EST https://www.sciencedaily.com/releases/2025/02/250207122748.htm https://www.sciencedaily.com/releases/2025/02/250205130931.htm Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune response after initiation of a personalized cancer vaccine. Wed, 05 Feb 2025 13:09:31 EST https://www.sciencedaily.com/releases/2025/02/250205130931.htm https://www.sciencedaily.com/releases/2025/02/250203141805.htm Maternal vitamin D levels in the first trimester were related to both prenatal growth and pregnancy outcomes, according to a new study. Low vitamin D levels during the first trimester of pregnancy were associated with higher rates of preterm birth and decreased fetal length. Mon, 03 Feb 2025 14:18:05 EST https://www.sciencedaily.com/releases/2025/02/250203141805.htm https://www.sciencedaily.com/releases/2025/01/250124154217.htm A research team made a pivotal discovery in the field of cancer immunotherapy. The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed acute myeloid leukemia (AML). Fri, 24 Jan 2025 15:42:17 EST https://www.sciencedaily.com/releases/2025/01/250124154217.htm https://www.sciencedaily.com/releases/2025/01/250124151010.htm Researchers find blocking the KCNB2 gene can slow tumor growth, paving the way for next-gen treatments for childhood brain cancer. Fri, 24 Jan 2025 15:10:10 EST https://www.sciencedaily.com/releases/2025/01/250124151010.htm https://www.sciencedaily.com/releases/2025/01/250123110236.htm New research looked at how cancers arise in children who are predisposed to developing the childhood kidney cancer, Wilms tumor, which could help anticipate the development of tumors before they fully form. Thu, 23 Jan 2025 11:02:36 EST https://www.sciencedaily.com/releases/2025/01/250123110236.htm https://www.sciencedaily.com/releases/2025/01/250116134058.htm Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer. Thu, 16 Jan 2025 13:40:58 EST https://www.sciencedaily.com/releases/2025/01/250116134058.htm https://www.sciencedaily.com/releases/2025/01/250114125014.htm A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a promising approach to bone healing and tumor control. Tue, 14 Jan 2025 12:50:14 EST https://www.sciencedaily.com/releases/2025/01/250114125014.htm https://www.sciencedaily.com/releases/2025/01/250109125643.htm Researchers have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used clinical risk factors. This could help doctors make more informed treatment decisions for people with stage 1 lung cancer, potentially reducing the risk of the cancer returning or spreading. Thu, 09 Jan 2025 12:56:43 EST https://www.sciencedaily.com/releases/2025/01/250109125643.htm